Current therapeutic strategies for inflammation following traumatic spinal cord injury

被引:26
作者
Singh, Priyanka L. [1 ,2 ]
Agarwal, Nitin [1 ,2 ]
Barrese, James C. [1 ]
Heary, Robert F. [1 ,2 ]
机构
[1] UMDNJ New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07101 USA
[2] Reynolds Family Spine Lab, Newark, NJ 07101 USA
关键词
acute spinal cord injury; inflammation; treatment; secondary injury; neuroprotective; hypothermia; erythropoietin; estrogen; etanercept; rolipram; ENHANCES NEUROLOGICAL RECOVERY; RANDOMIZED CONTROLLED-TRIAL; SYSTEMIC HYPOTHERMIA; FUNCTIONAL RECOVERY; AXONAL REGENERATION; TIRILAZAD MESYLATE; LOCOMOTOR FUNCTION; SECONDARY DAMAGE; CLINICAL-TRIALS; METHYLPREDNISOLONE;
D O I
10.3969/j.issn.1673-5374.2012.23.008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Damage from spinal cord injury occurs in two phases the trauma of the initial mechanical insult and a secondary injury to nervous tissue spared by the primary insult. Apart from damage sustained as a result of direct trauma to the spinal cord, the post-traumatic inflammatory response contributes significantly to functional motor deficits exacerbated by the secondary injury. Attenuating the detrimental aspects of the inflammatory response is a promising strategy to potentially ameliorate the secondary injury, and promote significant functional recovery. This review details how the inflammatory component of secondary injury to the spinal cord can be treated currently and in the foreseeable future.
引用
收藏
页码:1812 / 1821
页数:10
相关论文
共 60 条
  • [1] Anderson D K, 1985, Cent Nerv Syst Trauma, V2, P257
  • [2] Boran BO, 2005, RESTOR NEUROL NEUROS, V23, P341
  • [3] EFFICACY OF METHYLPREDNISOLONE IN ACUTE SPINAL-CORD INJURY
    BRACKEN, MB
    COLLINS, WF
    FREEMAN, DF
    SHEPARD, MJ
    WAGNER, FW
    SILTEN, RM
    HELLENBRAND, KG
    RANSOHOFF, J
    HUNT, WE
    PEROT, PL
    GROSSMAN, RG
    GREEN, BA
    EISENBERG, HM
    RIFKINSON, N
    GOODMAN, JH
    MEAGHER, JN
    FISCHER, B
    CLIFTON, GL
    FLAMM, ES
    RAWE, SE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (01): : 45 - 52
  • [4] METHYLPREDNISOLONE AND NEUROLOGICAL FUNCTION 1 YEAR AFTER SPINAL-CORD INJURY - RESULTS OF THE NATIONAL ACUTE SPINAL-CORD INJURY STUDY
    BRACKEN, MB
    SHEPARD, MJ
    HELLENBRAND, KG
    COLLINS, WF
    LEO, LS
    FREEMAN, DF
    WAGNER, FC
    FLAMM, ES
    EISENBERG, HM
    GOODMAN, JH
    PEROT, PL
    GREEN, BA
    GROSSMAN, RG
    MEAGHER, JN
    YOUNG, W
    FISCHER, B
    CLIFTON, GL
    HUNT, WE
    RIFKINSON, N
    [J]. JOURNAL OF NEUROSURGERY, 1985, 63 (05) : 704 - 713
  • [5] A RANDOMIZED, CONTROLLED TRIAL OF METHYLPREDNISOLONE OR NALOXONE IN THE TREATMENT OF ACUTE SPINAL-CORD INJURY - RESULTS OF THE 2ND NATIONAL ACUTE SPINAL-CORD INJURY STUDY
    BRACKEN, MB
    SHEPARD, MJ
    COLLINS, WF
    HOLFORD, TR
    YOUNG, W
    BASKIN, DS
    EISENBERG, HM
    FLAMM, E
    LEOSUMMERS, L
    MAROON, J
    MARSHALL, LF
    PEROT, PL
    PIEPMEIER, J
    SONNTAG, VKH
    WAGNER, FC
    WILBERGER, JE
    WINN, HR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (20) : 1405 - 1411
  • [6] Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up - Results of the third National Acute Spinal Cord Injury randomized controlled trial
    Bracken, MB
    Shepard, MJ
    Holford, TR
    Leo-Summers, L
    Aldrich, EF
    Fazl, M
    Fehlings, MG
    Herr, DL
    Hitchon, PW
    Marshall, LF
    Nockels, RP
    Pascale, V
    Perot, PL
    Piepmeier, J
    Sonntag, VKH
    Wagner, F
    Wilberger, JE
    Winn, HR
    Young, W
    [J]. JOURNAL OF NEUROSURGERY, 1998, 89 (05) : 699 - 706
  • [7] Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury - Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial
    Bracken, MB
    Shepard, MJ
    Holford, TR
    LeoSummers, L
    Aldrich, EF
    Fazl, M
    Fehlings, M
    Herr, DL
    Hitchon, PW
    Marshall, LF
    Nockels, RP
    Pascale, V
    Perot, PL
    Piepmeier, J
    Sonntag, VKH
    Wagner, F
    Wilberger, JE
    Winn, HR
    Young, W
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (20): : 1597 - 1604
  • [8] EVALUATION OF AN INTENSIVE METHYLPREDNISOLONE SODIUM SUCCINATE DOSING REGIMEN IN EXPERIMENTAL SPINAL-CORD INJURY
    BRAUGHLER, JM
    HALL, ED
    MEANS, ED
    WATERS, TR
    ANDERSON, DK
    [J]. JOURNAL OF NEUROSURGERY, 1987, 67 (01) : 102 - 105
  • [9] Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury
    Brines, ML
    Ghezzi, P
    Keenan, S
    Agnello, D
    de Lanerolle, NC
    Cerami, C
    Itri, LM
    Cerami, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) : 10526 - 10531
  • [10] Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury
    Casha, Steven
    Zygun, David
    McGowan, M. Dan
    Bains, Ish
    Yong, V. Wee
    Hurlbert, R. John
    [J]. BRAIN, 2012, 135 : 1224 - 1236